No randomized, double-blind placebo controlled trial has demonstrated a reduction in mortality as a primary or secondary endpoint for these products. That is the only standard by which a model could be constructed. Death did not go down with mass indiscriminate use--it went up. https://t.co/6c9PqdDRg1

— Peter A. McCullough, MD, MPH® (@P_McCulloughMD) December 16, 2022